Biophysical characterization of insoluble aggregates of a multi-domain protein: An insight into the role of the various domains

Journal of Pharmaceutical Sciences

Volumn 94, Issue 9, 2005, Pages 2069-2083

  Souillac, Pierre O ^a  

^a BIOGEN   (United States)

Author keywords

Immunoglobin; Insoluble aggregates; Mercaptoethanol; Protein

Indexed keywords

GLYCOPROTEIN; GUANIDINE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; MERCAPTOETHANOL; UREA;

ARTICLE; BIOPHYSICS; COVALENT BOND; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN FOLDING; SOLUBILITY; SOLUBILIZATION;

EID: 27644507768     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20423     Document Type: Article

References (28)

1. Fink AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3: 9-23.
2. Harper JD, Wong SS, Lieber CM, Lansbury PT, Jr. 1999. Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38:8972-8980.
3. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. 2002. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277: 21140-21148.
4. Buxbaum J. 1992. Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 6:323-346.
5. Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20:1325-1336.
6. Grillo AO, Edwards KL, Kashi RS, Shipley KM, Hu L, Besman MJ, Middaugh CR. 2001. Conformational origin of the aggregation of recombinant human factor VIII. Biochemistry 40:586-595.
7. Treuheit MJ, Kosky AA, Brems DN. 2002. Inverse relationship of protein concentration and aggregation. Pharm Res 19:511-516.
8. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. 1997. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272:22364-22372.
9. Kendrick BS, Cleland JL, Lam X, Nguyen T, Randolph TW, Manning MC, Carpenter JF. 1998. Aggregation of recombinant human interferon gamma: Kinetics and structural transitions. J Pharm Sci 87:1069-1076.
10. Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, Millett I, Fink AL. 2001. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40:3525-3535.
11. Manning MC, Patel K, Borchardt RT. 1989. Stability of protein pharmaceuticals. Pharm Res 6:903-918.
12. Volkin DB, Mach H, Middaugh CR. 1997. Degradative covalent reactions important to protein stability. Mol Biotechnol 8:105-122.
13. Chen BL, Arakawa T, Morris CF, Kenney WC, Wells CM, Pitt CG. 1994. Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization. Pharm Res 11:1581-1587.
14. Kendrick BS, Carpenter JF, Cleland JL, Randolph TW. 1998. A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. Proc Natl Acad Sci USA 95:14142-14146.
15. Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW. 2003. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. Protein Sci 12:903-913.
16. Roberts CJ, Darrington RT, Whitley MB. 2003. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. J Pharm Sci 92:1095-1111.
17. Uversky VN, Fink AL. 2004. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim Biophys Acta 1698:131-153.
18. Polverino de Laureto P, Taddei N, Frare E, Capanni C, Costantini S, Zurdo J, Chiti F, Dobson CM, Fontana A. 2003. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J Mol Biol 334:129-141.
19. Uversky VN. 1999. A multiparametric approach to studies of self-organization of globular proteins. Biochemistry (Moscow) 64:250-266.
20. Pace CN, Scholtz JM. 1997. Measuring the conformational stability of a protein. In: Creighton TE, editor. Protein: A practical approach, 2nd edn. New York: Oxford University Press Inc, pp 299-321.
21. c fragments from myeloma immunoglobulin G. Biochemistry 37:5576-5581.
22. Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, Goodall M, Lund J, Jefferis R. 2000. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: Properties of a series of truncated glycoforms. Mol Immunol 37:697-706.
23. Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, Goodall M, Jefferis R. 2001. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 276:45539-45547.
24. Goto Y, Hamaguchi K. 1982. Unfolding and refolding of the constant fragment of the immunoglobulin light chain. J Mol Biol 156:891-910.
25. Goto Y, Hamaguchi K. 1982. Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond. J Mol Biol 156:911-926.
26. Sumi A, Hamaguchi K. 1982. Denaturation by guanidine hydrochloride of the Fc(t) and pFc' fragments of human immunoglobulin G. J Biochem 92:823-833.
27. Stryer L. 1968. Fluorescence spectroscopy of proteins: Fluorescent probes provide insight into the structure, interactions, and dynamics of proteins. Science 162:526-533.
28. Semisotnov GV, Rodionova NA, Razgulyaev OI, Uversky VN, Gripas AF, Gilmanshin RI. 1991. Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31:119-128.